More recently, omega-3 fatty acids, which are known agonists of FFAR1 and FFAR4, have shown efficacy in treating NAFLD, NASH, alcoholic hepatitis, and IFALD. The gene discussed is FFAR4; the disease is metabolic dysfunction-associated steatohepatitis.